Back to today’s briefing

Story perspectives

Trial Tests taVNS Device for Depression and Anxiety

10/4/2025

49 8

Summary

Story summary

A trial at Spaulding Rehabilitation Hospital, Cambridge, MA, enrolled 44 participants to test taVNS for depression and anxiety.
Participants were randomized to active or sham taVNS, with strict safety criteria.
Healaon taVNS device delivered 60 minutes of stimulation with safety parameters.
EEG data were collected pre- and post-intervention, focusing on delta, theta, and alpha bands, with blinding and artifact correction.

1 of 1

Story summary

A trial at Spaulding Rehabilitation Hospital, Cambridge, MA, enrolled 44 participants to test taVNS for depression and anxiety.
Participants were randomized to active or sham taVNS, with strict safety criteria.
Healaon taVNS device delivered 60 minutes of stimulation with safety parameters.
EEG data were collected pre- and post-intervention, focusing on delta, theta, and alpha bands, with blinding and artifact correction.